Related Experiment Video
Updated: Jan 2, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis
Mohammed Alshaikheid1, Amel Chaabane1, Nadia Ben Fredj1
1Laboratory of Pharmacology, Faculty of Medicine of Monastir, Monastir, Tunisia.
A new limited sampling strategy (LSS) using isoniazid concentrations at specific time points (C0 and C3) accurately predicts the 24-hour area under the curve (AUC) in Tunisian patients. This practical method aids therapeutic drug monitoring for extrapulmonary tuberculosis.
Area of Science:
- Pharmacokinetics and Therapeutic Drug Monitoring
- Tuberculosis Treatment and Management
- Population Pharmacokinetics
Background:
- Limited sampling strategies (LSS) are valuable for predicting drug exposure, specifically the area under the concentration-time curve (AUC).
- Isoniazid pharmacokinetics and LSS development are scarce in South-Mediterranean populations, particularly for extrapulmonary tuberculosis.
- Accurate prediction of isoniazid AUC is crucial for optimizing treatment efficacy and minimizing toxicity.
Purpose of the Study:
- To develop and validate a convenient and accurate limited sampling strategy (LSS) for predicting isoniazid's 24-hour AUC.
- To evaluate the performance of different LSS models in Tunisian patients with extrapulmonary tuberculosis.
- To establish a practical method for therapeutic drug monitoring of isoniazid in this specific population.
Main Methods:
- Pharmacokinetic data were collected from 25 Tunisian patients with extrapulmonary tuberculosis, with six blood samples drawn per 24-hour dosing interval.
- Area under the curve (AUC) was calculated using the linear trapezoidal rule, and isoniazid concentrations were correlated with AUC via linear regression.
- Predictive performance of various LSS models was assessed using error indices (e.g., %MAE, %RMSE) and Bland-Altman/mountain plot analyses.
Main Results:
- A 1-time-point LSS using C3 concentration (isoniazid level at 3 hours) showed high correlation (r² = .906) with measured AUC.
- A 2-time-point LSS combining C2 and C6 concentrations yielded the highest correlation (r² = .960) and lowest prediction error.
- The C0/C3 LSS model demonstrated satisfactory accuracy (r² = .930), and a 3-time-point model (C0, C1, C6) achieved the best prediction (r² = .992).
Conclusions:
- The C0/C3 limited sampling strategy (LSS) provides a reliable, accurate, and practical method for estimating isoniazid AUC in Tunisian extrapulmonary tuberculosis patients.
- A single-time point LSS using C3 concentration is a viable alternative for clinical practice due to its acceptable accuracy and practicality.
- The findings support the implementation of LSS for therapeutic drug monitoring of isoniazid, enhancing treatment management in similar populations.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Dosage Regimens: Partial Pharmacokinetic Parameters